Laura Barnabei

Here below are the publications (2) participated by Laura Barnabei along with Afua Adjeiwaa Mensah (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations).

Any wrong or incomplete data? Any missing, misplaced, unlicensed picture? Please report any abuse, inaccuracy or lack of information to info@ticinoscienza.ch

1) ERBB4-mediated signaling is a mediator of resistance to BTK and PI3K inhibitors in B cell lymphoid neoplasms

bioRxiv, 2 gennaio 2023

2) Resistance to PI3Kδ inhibitors in marginal zone lymphoma can be reverted by targeting the IL-6/PDGFRA axis

Haematologica, 1 novembre 2022

Facts & figures

Laura Barnabei has coordinated or participated in 5 publications
(as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) whose subjects can be represented by this 9 elements tag cloud:

B cell lymphoid (1) BTK (1) hematologic cancers (1) IRAK4 (1) lymphoma (1) marginal zone lymphoma (1) MYD88 (1) PI3K (1) Wiskott-Aldrich syndrome (1)

Laura Barnabei has coordinated or participated in 5 publications (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) featured by 3 scientific journals:

Haematologica (3) bioRxiv (1) Journal of Clinical Medicine (1)

Laura Barnabei has coordinated or participated in 5 publications (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) involving also 29 co-authors being active in Ticino:

Giulio Sartori (5) Francesco Bertoni (5) Filippo Spriano (5) Emanuele Zucca (5) Luciano Cascione (4) Eugenio Gaudio (4) Chiara Tarantelli (4) Anastasios Stathis (4) Andrea Rinaldi (4) Alberto Jesus Arribas (4) Greta Guarda (2) Franco Cavalli (2) Afua Adjeiwaa Mensah (2) Sara Napoli (2) Jacopo Sgrignani (2) Gaetanina Golino (2) Georg Stussi (2) Francesco Margheriti (2) Andrea Cavalli (2) Alberto Furlan (2) Sandra Jovic (2) Pedro Ventura (2) Chaira Tarantelli (1) Alberto J. Arribas (1) Roberta Bordone Pittau (1) Davide Rossi (1) Roberta Bordone-Pittau (1) Eleonora Cannas (1) Francesca Guidetti (1)

Laura Barnabei has coordinated or participated in 5 pubblications (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) in whose synopsis the 22 most frequently used terms (excluding 24 not relevant terms) are here listed:

L.B. WORD CLOUD pi (3) lymphoma (2) btk (2) first-in-class (2) wiskott-aldrich (2) activator (2) hematologic (2) cancers (2) reverted (1) il (1) pdgfra (1) axis (1) irak (1) emavusertib (1) erbb (1) mediated (1) signaling (1) mediator (1) lymphoid (1) neoplasms (1) antitumor (1) anti-tumor (1)

In the synopsis of the whole 3138 pubblications (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations), the 173 most frequently used terms (excluding 24 not relevant or unfrequently used terms (terms used less than 10 times) are here listed:

THE WHOLE WORD CLOUD cancer (281) covid- (182) thyroid (108) sars-cov- (102) prostate (101) pet (101) cardiac (97) hiv (83) atrial (75) coronary (75) breast (74) pandemic (67) sclerosis (67) lymphoma (66) fibrillation (65) bone (53) aortic (51) artery (49) heart (48) liver (46) stroke (46) brain (43) carcinoma (43) antibodies (41) lung (38) mri (38) cardiovascular (36) transcatheter (35) ventricular (35) nodules (34) dna (34) virus (33) extracellular (32) metastatic (32) myocardial (31) tumor (30) kidney (29) oncology (29) ultrasound (28) knee (27) esmo (26) f-fdg (26) antibody (26) vesicles (25) spinal (25) mitral (25) hepatitis (24) ischemic (23) cervical (23) infarction (22) tuberculosis (22) ehra (22) antiplatelet (22) diabetes (22) sperm (22) pulmonary (21) radiotherapy (21) chemotherapy (21) renal (21) ovarian (21) percutaneous (21) osteoarthritis (20) implantation (20) vaccination (20) sentinel (20) transplantation (19) blood (19) nuclear (18) urinary (18) tomography (18) pacing (18) tumors (18) bacterial (18) b-cell (17) resonance (17) endovascular (17) monoclonal (17) bladder (17) lymph (17) laparoscopic (17) colorectal (17) mice (17) coronavirus (16) immunodeficiency (16) transplant (15) musculoskeletal (15) vascular (15) fdg (15) implantable (15) lymphomas (14) plasma (14) vaccine (14) fractures (14) peripheral (14) neurocognitive (14) leukemia (14) autoimmune (13) mrna (13) biomarker (13) nerve (13) pneumonia (13) biomarkers (13) radiomics (13) metabolic (13) tricuspid (13) preclinical (13) metabolism (13) serum (13) metastasis (13) pregnancy (13) lymphocytic (13) conference (12) malignancy (12) membrane (12) grafts (12) ischemia (12) endometrial (12) fna (12) joint (12) brugada (12) antiretroviral (12) legs (12) male (12) arterial (12) dementia (12) esc (12) hemorrhage (12) behavior (12) pi (11) burden (11) cytology (11) signaling (11) pathways (11) contemporary (11) adherence (11) catheter (11) contrast-enhanced (11) limb (11) tau (11) parkinson (11) radiation (11) senescence (11) neck (11) hiv- (11) mesenchymal (11) lockdown (11) mutations (11) medullary (11) il- (11) infectious (10) cancers (10) igg (10) intravenous (10) arrhythmia (10) vitamin (10) interventions (10) prophylaxis (10) migraine (10) follicular (10) gastric (10) prognosis (10) metastases (10) skin (10) incontinence (10) muscle (10) anesthesia (10) epidemiology (10) lipid (10) baseline (10) refractory (10) malignant (10) occlusion (10) dynamic (10)

Scientific researchers in Ticino

Laura Barnabei has participated - as a whole - in 5 publications (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) - here below are the ones participated along with Afua Adjeiwaa Mensah

1) ERBB4-mediated signaling is a mediator of resistance to BTK and PI3K inhibitors in B cell lymphoid neoplasms

2) Resistance to PI3Kδ inhibitors in marginal zone lymphoma can be reverted by targeting the IL-6/PDGFRA axis

Laura Barnabei has participated - as a whole - in 5 publications
(as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) - here below are the ones participated along with Afua Adjeiwaa Mensah